Stay updated on Amivantamab Clinical Trial in Advanced NSCLC
Sign up to get notified when there's something new on the Amivantamab Clinical Trial in Advanced NSCLC page.

Latest updates to the Amivantamab Clinical Trial in Advanced NSCLC page
- Check2 days agoChange DetectedA new CHRYSALIS publication citation was added to Publications. The record was updated to revision v3.5.4 with corresponding date markers.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision tag changed from v3.5.2 to v3.5.3, indicating a new build of the page without changes to the visible content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedNew revision entries were added for 2026-04-13, 2026-04-09, and 2026-04 (Revision: v3.5.2); older entries from 2026-01-16, 2026-01-15, and 2026-01 (Revision: v3.5.0) were removed.SummaryDifference0.2%

- Check52 days agoChange Detected- Revision: v3.5.0 was added to reflect the latest page revision, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check66 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. This appears to be a minor administrative update and does not modify study content.SummaryDifference0.0%

- Check95 days agoChange DetectedAdded a minor site revision tag (Revision: v3.4.2) and removed a general government funding notice; the study details and page content remain unchanged.SummaryDifference0.3%

Stay in the know with updates to Amivantamab Clinical Trial in Advanced NSCLC
Enter your email address, and we'll notify you when there's something new on the Amivantamab Clinical Trial in Advanced NSCLC page.